Oracles, Billion

Oracle's $42 Billion Cash Flow Deficit Underscores the Cost of Its AI Infrastructure Bet

Published on 07/17/2026 at 18:22 | Redaktion boerse-global.de

Oracle shares hit €105.10 low, down 60% from peak, as massive data center capex and $40B funding plan outweigh 93% OCI revenue growth and $638B backlog.

Oracle Stock Tumbles to 52-Week Low on $95B Cloud Spending, Dilution Fears
Oracle's $42 Billion Cash Flow Deficit Underscores the Cost of Its AI Infrastructure Bet Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Oracle's transformation from a high-margin software fortress into a capital-intensive cloud infrastructure provider is playing out in brutal fashion on the stock market. The shares touched a fresh 52-week low of €105.10 on Friday, extending a decline that has wiped out roughly 60% of the company's value since the September 2025 peak of €280.70. At €110.20, the stock sits 33.7% lower year-to-date and nearly 49% below its level twelve months ago.

The sell-off is not a reaction to weak demand. Oracle's cloud infrastructure business (OCI) posted 93% revenue growth in the latest quarter, its GPU fleet runs at 97.5% utilization, and the order backlog stands at a staggering $638 billion — fueled largely by a multi-year deal with OpenAI. The problem lies squarely on the other side of the balance sheet: the cost of building the data centers needed to fulfill those contracts is overwhelming Oracle's cash generation.

Capital expenditure for fiscal 2027 is projected at up to $95 billion, and the company expects a free cash flow deficit of roughly $42 billion in the coming fiscal year. To bridge that gap, Oracle is tapping the capital markets for $40 billion, including $20 billion in fresh equity sold on the open market. That dilution — more shares outstanding, lower earnings per share — adds a second layer of pain for investors already staring at a 52-week low. Over the past month alone, the stock has shed nearly 31%.

Should investors sell immediately? Or is it worth buying Oracle?

S&P Global recently downgraded Oracle's credit rating to BBB-, just one notch above junk, citing elevated credit risk from the aggressive expansion. Total debt has climbed to $130 billion, and while the company plans to avoid new debt in 2026, the reliance on equity financing perpetuates the dilution cycle. Meanwhile, Oracle has cut 21,000 jobs over the past year, signaling that management is prioritizing infrastructure investment above all else.

The tension between the operational story and the financial reality is most visible in the gap between the stock price and analysts' expectations. The consensus price target stands at roughly €220, implying more than 100% upside from current levels. With a market capitalization of €321.8 billion, Oracle remains a heavyweight, but the market is pricing in the financing risk rather than the long-term contract value. The stock's 14-day relative strength index has sunk to 28.5, dipping as low as 26.5 in recent sessions — deep in oversold territory — and the 30-day annualized volatility has topped 46%.

Oracle is not alone in this predicament. Every major technology company is racing to build AI infrastructure, and fears of overcapacity and weak returns are spreading across the sector. But the difference is that rivals like Amazon, Microsoft and Google generate massive cash flows to fund the build-out. Oracle is trying to match their pace without that cushion, effectively borrowing from its own future to construct that future.

Amid the turmoil, Oracle continues to pay a quarterly dividend of $0.50 per share, which went ex-dividend on July 10, 2026. That payout provides a small anchor for income-focused investors, but the bigger question is whether it can remain comfortably covered as capital spending heads toward $70 billion in net investment alone. The market's verdict on Oracle's AI wager is still far from final.

Ad

Oracle Stock: New Analysis - 17 July

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLES | boerse | 69788592 |